Annovis Bio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $45,035,011.

Profit Margin

Annovis Bio, Inc. (NYSE:ANVS): Profit margin
2017 0 -682.34K
2018 0 -713.87K
2019 0 -296.83K
2020 0 -4.25M
2021 0 -14.43M
2022 0 -25.14M
2023 0 -56.20M

ANVS Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue
0000000
Cost of revenue
0000000
Gross profit
0000000
Operating exp.
Research and development
38.79M16.51M8.47M3.05M776.25K111.60K273.37K
Selling and marketing
0000000
Total operating expenses
45.03M25.51M14.50M5.48M870.54K713.93K682.43K
Operating income
-45.03M-25.51M-14.53M-6.64M-1.60M-713.93K-682.43K
Other income (expenses), net
-11.16M182.71K50.08K1.17M614.64K6684
Income before tax
-56.20M-25.32M-14.48M-5.46M-990.98K-713.87K-682.34K
Income tax expense
0-182.71K-50.08K-1.20M-694.14K-132-682.43K
Net income
-56.20M-25.14M-14.43M-4.25M-296.83K-713.87K-682.34K
Earnings per share
Basic EPS
-6.23-3.08-1.89-0.67-0.04-0.16-0.16
Diluted EPS
-6.23-3.08-1.89-0.67-0.04-0.16-0.16
Data sourceData sourceData sourceData sourceData source